These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8991942)

  • 1. Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody.
    Nagasaka A; Hige S; Kurosawa M; Yoshida J; Karino Y; Toyota J; Matsushima T; Asaka M
    J Med Virol; 1996 Jun; 49(2):91-4. PubMed ID: 8991942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
    Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C.
    Kao JH; Chen PJ; Yang PM; Lai MY; Wang TH; Chen DS
    J Med Virol; 1996 Jun; 49(2):87-90. PubMed ID: 8991941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic relevance of F protein in chronic hepatitis C virus infection.
    Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
    Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b.
    Okamoto K; Akuta N; Kumada H; Kobayashi M; Matsuo Y; Tazawa H
    J Virol Methods; 2007 Apr; 141(1):1-6. PubMed ID: 17184852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.
    Christie JM; Chapel H; Chapman RW; Rosenberg WM
    Hepatology; 1999 Oct; 30(4):1037-44. PubMed ID: 10498657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.